The appeal of wanting to feel pain during sexual activity may be linked to the release of ...

Author Question: The appeal of wanting to feel pain during sexual activity may be linked to the release of ... (Read 128 times)

ishan

Hero Member
Posts: 546

on: Jun 22, 2018

The appeal of wanting to feel pain during sexual activity may be linked to the release of endorphins.

Indicate whether the statement is true or false

Question 2

Frotteurism involves deriving sexual excitement and orgasm from being in the same room as the target of the paraphilia (usually an attractive woman).

Indicate whether the statement is true or false

scrocafella

Sr. Member
Posts: 346

Reply #1 on: Jun 22, 2018

Answer to Question 1

TRUE

Answer to Question 2

Great help.

Need homework help now?

Ask unlimited questions for free

Ask a Question

« previous next »

Did you know?

Blastomycosis is often misdiagnosed, resulting in tragic outcomes. It is caused by a fungus living in moist soil, in wooded areas of the United States and Canada. If inhaled, the fungus can cause mild breathing problems that may worsen and cause serious illness and even death.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

Hip fractures are the most serious consequences of osteoporosis. The incidence of hip fractures increases with each decade among patients in their 60s to patients in their 90s for both women and men of all populations. Men and women older than 80 years of age show the highest incidence of hip fractures.

Did you know?

A serious new warning has been established for pregnant women against taking ACE inhibitors during pregnancy. In the study, the risk of major birth defects in children whose mothers took ACE inhibitors during the first trimester was nearly three times higher than in children whose mothers didn't take ACE inhibitors. Physicians can prescribe alternative medications for pregnant women who have symptoms of high blood pressure.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.